Commercialization of an Advanced Technology for T Cell Receptor Analysis and Engineering

Information

• Research Project
• 9193662

• ApplicationId

  9193662

• Core Project Number

  R43AI120313

• Full Project Number

  3R43AI120313-01S1

• Serial Number

  120313

• FOA Number

  PA-16-019

• Sub Project Id

• Project Start Date

  3/11/2016 - 8 years ago

• Project End Date

  5/31/2016 - 8 years ago

• Program Officer Name

  MINNICOZZI, MICHAEL

• Budget Start Date

  3/11/2016 - 8 years ago

• Budget End Date

  5/31/2016 - 8 years ago

• Fiscal Year

  2016

• Support Year

  01

• Suffix

  S1

• Award Notice Date

  3/11/2016 - 8 years ago

Organizations

• GIGAGEN, INC.

? DESCRIPTION (provided by applicant): An Advanced Tool for T Cell Analysis Using Microfluidics Organization: GigaGen Inc. PI: David S. Johnson, Ph.D. Better methods for discovery and monitoring of immune system biomarkers could improve treatment of a variety of diseases and conditions, including cancer, autoimmune diseases, allergies, transplant rejection, and infectious diseases. We are building a novel technology that uses microfluidics and DNA sequencing to understand the immune system in unprecedented ways.

IC Name

• Activity

  R43

• Administering IC

  AI

• Application Type

  3

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  40000

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  855

• Ed Inst. Type

• Funding ICs

  NIAID:40000\

• Funding Mechanism

  SBIR-STTR RPGs

• Study Section

• Study Section Name

• Organization Name

  GIGAGEN, INC.

• Organization Department

• Organization DUNS

  963285189

• Organization City

  SOUTH SAN FRANCISCO

• Organization State

  CA

• Organization Country

  UNITED STATES

• Organization Zip Code

  940804819

• Organization District

  UNITED STATES